Open AccessTO DETERMINE THE SERUM PROLACTIN LEVELS IN BREAST CARCINOMA: A CASE CONTROL STUDY
Author(s) -
. Sahun,
Sumita Jain,
. Ashutosh,
Dikhsa Mehta
Publication year - 2020
Publication title -
international journal of medical and biomedical studies
Language(s) - English
Resource type - Journals
eISSN - 2589-8698
pISSN - 2589-868X
DOI - 10.32553/ijmbs.v4i10.1456
Subject(s) - prolactin , medicine , breast cancer , cancer , case control study , oncology , gynecology , hormone
Background: Breast cancer is the most common female cancer worldwide representing nearly a quarter (25%) of all cancers with an estimated 1.67 million new cancer cases diagnosed in 2012.
Methods: The study was conducted in the Department of General Surgery, SMS Hospital, Jaipur. Study duration: From March 2018 to February 2019 (1 year).
Results: In Cancer cases, Mean Serum Prolactin level was found to be 14.71±16.73 while in control it was 8.26±5.60 .Mean Serum insulin level was higher in Cancer cases (14.71) as compared to control (8.26).Range of prolactin level in breast cancer cases from 2.84 to 103.71 and Range of prolactin level in controls was from 2.79 to 33.12 Difference was found to significant.
Conclusion: By this study we can interpretate that serum prolactin level is an independent factor and can be used to know the risk of breast cancer in postmenopausl women. whenever serum prolactin level is raised in these women, we can advise necessary measure to these women to prevent or identify early breast cancer.
Keywords: Breast, cancer, Female